» Articles » PMID: 36159524

Intranasal Sufentanil Combined with Intranasal Dexmedetomidine: A Promising Method for Non-anesthesiologist Sedation During Endoscopic Ultrasonography

Overview
Specialty General Medicine
Date 2022 Sep 26
PMID 36159524
Authors
Affiliations
Soon will be listed here.
Abstract

Intranasal sufentanil combined with intranasal dexmedetomidine exhibited an estimated sedation success probability as high as 94.9%, higher satisfaction scores, and only minor adverse events during endoscopic ultrasonography (EUS). This is a promising method for EUS sedation that does not require the presence of an anesthesiologist.

References
1.
Sidhu R, Turnbull D, Newton M, Thomas-Gibson S, Sanders D, Hebbar S . Deep sedation and anaesthesia in complex gastrointestinal endoscopy: a joint position statement endorsed by the British Society of Gastroenterology (BSG), Joint Advisory Group (JAG) and Royal College of Anaesthetists (RCoA). Frontline Gastroenterol. 2019; 10(2):141-147. PMC: 6540268. DOI: 10.1136/flgastro-2018-101145. View

2.
Guimaraes E, Campbell E, Richter J . The safety of nurse-administered procedural sedation compared to anesthesia care in a historical cohort of advanced endoscopy patients. Anesth Analg. 2014; 119(2):349-356. DOI: 10.1213/ANE.0000000000000258. View

3.
Zou Y, Li N, Shao L, Liu F, Xue F, Tao X . Determination of the ED of intranasal sufentanil combined with intranasal dexmedetomidine for moderate sedation during endoscopic ultrasonography. World J Clin Cases. 2022; 10(9):2773-2782. PMC: 8968820. DOI: 10.12998/wjcc.v10.i9.2773. View

4.
Teh J, Shabbir A, Yuen S, So J . Recent advances in diagnostic upper endoscopy. World J Gastroenterol. 2020; 26(4):433-447. PMC: 7002908. DOI: 10.3748/wjg.v26.i4.433. View

5.
De Lisi S, Giovannini M . Endoscopic ultrasonography: Transition towards the future of gastro-intestinal diseases. World J Gastroenterol. 2016; 22(5):1779-86. PMC: 4724609. DOI: 10.3748/wjg.v22.i5.1779. View